Medindia

X

Eclipsys to Present at Thomas Weisel Partners Healthcare Conference

Thursday, August 30, 2007 General News J E 4
Advertisement
BOCA RATON, Fla., Aug. 29 EclipsysCorporation(R) (Nasdaq: ECLP), The Outcomes Company(R), today announced itwill be participating in the Thomas Weisel Partners Healthcare Conference2007, taking place in Boston, MA on Wednesday, September 5th.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO )

This conference will include a presentation by Robert J. Colletti,Eclipsys senior vice president and chief financial officer. The presentationwill begin at 8:00 a.m. Eastern time. Interested parties are invited to listento the presentation via webcast athttp://www.veracast.com/webcasts/twp/healthcare07/39101206.cfm. Listeners areencouraged to log on to the Web site approximately 10 minutes prior to thepresentation start time to download the necessary software. A replay of thewebcast will be archived in the Investor Relations area of the Eclipsys Website following the presentation.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenuecycle and access management software, clinical content and professionalservices that help healthcare organizations improve clinical, financial,operational and client satisfaction outcomes. For more information, seewww.eclipsys.com or email info@eclipsys.com.

Management's prepared remarks and answers to questions during thepresentation referenced in this release will include forward-lookingstatements, including concerning the company's sales, marketing andoperational initiatives, future financial results, operating performance,development efforts, and the benefits provided by Eclipsys software andservices. Actual results may differ from those projected due to a variety ofrisks and uncertainties. Future performance expectations are predicated uponachievement of various sales and performance targets that may be difficult tomeet. Sales may be slower than expected due to market conditions,competition, and other factors. Costs may be greater than anticipated due tothe potential need to increase spending to ensure performance in accordancewith commitments to clients and other factors. Software development may takelonger and cost more than expected, and incorporation of anticipated featuresand functionality may be delayed, due to various factors including programmingand integration challenges and resource constraints. The market is highlycompetitive. Implementation and customization of Eclipsys software is complexand time-consuming. Results depend upon a variety of factors and can vary byclient. Each client's circumstances are unique and may include unforeseenissues that make it more difficult than anticipated to implement or derivebenefit from software, implementation or consulting services. The success andtimeliness of the company's services will depend at least in part upon clientinvolvement, which can be difficult to control. Eclipsys is required to meetspecified performance standards, and clients can terminate contracts, assesspenalties or reduce contract scope under certain circumstances. Moreinformation about company risks is available in recent Form 10-K and otherfilings made by Eclipsys from time to time with the Securities and ExchangeCommission. Special attention is directed to the portions of those documentsentitled "Risk Factors" and "Management's Discussion and Analysis of FinancialCondition and Results of Operations." Eclipsys Corporation and The OutcomesCompany are registered trademarks of Eclipsys Corporation.Eclipsys Jason Cigarran Robert J. Colletti Director, Media Relations Chief Financial Officer (investors) (561) 322-4355 (561) 322-4655 jason.cigarran@eclipsys.com investor.relations@eclipsys.com

SOURCE Eclipsys Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Winner New Product Update: Advanced Dressings and ...
S
Thoratec Presentation At Thomas Weisel Partners Co...